PBPH vs TVAL5YPBPHPBPHAvsBTVALTVALPortfolio Building Block World Pharma and Biotech Index ETF · $1.3BT. Rowe Price Value ETF · $1.1BReturns · dividends in[…]3 years · per year[…] · $18,154+22.0%[…]5 years · per year[…]Cost and income0.13%Expense ratio$13 · $33 on $10k · lower wins0.33%0.07%12-mo yield$7 · $92 on $10k0.92%Risk · 1 year
$10,000 in PBPH, TVAL, VGT5Y$10k startVGT $20.9kNov 2021Nov 2026End-of-day Nov 10, 2026 · growth of $10,000, dividends reinvested · from each fund’s start inside the window
Overlap: PBPH, TVAL, VGTToday6.8%most shared, PBPH and TVALPBPHTVALVGTPBPH—6.8%0.0%TVAL6.8%—4.8%VGT0.0%4.8%—End-of-day Nov 10, 2026 · share held in common · outlined: the pair in versus
PBPH vs TVAL5YAPBPHPortfolio Building Block World Pharma and Biotech Index[…]vsTVALBT. Rowe Price Value[…]MeasurePBPHTVALFee0.13%0.33%Cost on $10k a year$13$33Yield0.07%0.92%5 years, per year[…][…]3 years, per year[…]+22.0%Worst drop · 1Y[…]−7.2%Volatility · 1Y[…]11.3%
All Three5Y3 fundsBest 5YLowest feeHighest incomeSmallest dropMost assets#Ticker▲▼Fund▲▼TrendFee▲▼Yield▲▼Today▲▼YTD▲▼1Y▲▼3Y/yr▲▼5Y/yr▼Drop▲▼Assets▲▼1VGTVanguard Information Technology ETFReadDesk0.09%0.43%−1.3%+17.7%+16.7%+28.1%+15.8%−17.5%$154.5B2APBPHPortfolio Building Block World Pharma and Biotech Index ETFReadDesk0.13%0.07%−0.2%+25.4%newnewnew[…]$1.3B3BTVALT. Rowe Price Value ETFReadDesk0.33%0.92%+0.1%+25.7%+30.5%+22.0%new−7.2%$1.1BEnd-of-day Nov 10, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus
All Three5Y3 fundsBest 5YLowest feeHighest incomeSmallest dropMost assets#Ticker▲▼Fund▲▼TrendFee▲▼Yield▲▼Today▲▼YTD▲▼1Y▲▼3Y/yr▲▼5Y/yr▼Drop▲▼Assets▲▼1VGTVanguard Information Technology ETFReadDesk0.09%0.43%−1.3%+17.7%+16.7%+28.1%+15.8%−17.5%$154.5B2APBPHPortfolio Building Block World Pharma and Biotech Index ETFReadDesk0.13%0.07%−0.2%+25.4%newnewnew[…]$1.3B3BTVALT. Rowe Price Value ETFReadDesk0.33%0.92%+0.1%+25.7%+30.5%+22.0%new−7.2%$1.1BEnd-of-day Nov 10, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus
XLK vs VGTYTDSPDRXLKSA+17.7%vsBVVGTVanguard+17.7%Jan 1Nov 10+17.7%+17.7%+17.7%Year to date+17.7%0.08% · $8Fee · on $10k a year0.09% · $9$110BAssets$155B1–0XLK winsEnd-of-day Nov 10, 2026
SCHD vs VIGYTDSchwabSCHDSA+33.8%vsBVVIGVanguard+15.1%Jan 1Nov 10+33.8%+15.1%+33.8%Year to date+15.1%2.9%Yield1.5%$122BAssets$109B2–0SCHD winsEnd-of-day Nov 10, 2026
JEPQ vs JEPIYTDJ.P. MorganJEPQJMA+6.0%vsBJMJEPIJ.P. Morgan+7.6%Jan 1Nov 10+6.0%+7.6%+6.0%Year to date+7.6%12.4%Yield7.9%$40.7BAssets$45.2B1–1levelEnd-of-day Nov 10, 2026
Overlap: PBPH, TVAL, VGTToday6.8%most shared, PBPH and TVALPBPHTVALVGTPBPH—6.8%0.0%TVAL6.8%—4.8%VGT0.0%4.8%—End-of-day Nov 10, 2026 · share held in common · outlined: the pair in versus
Income After Fees on $10,0001Y$59most kept, TVALTVAL$92 − $33 = $59VGT$43 − $9 = $34PBPH$7 − $13 = −$6KeptFeeEnd-of-day Nov 10, 2026 · yield in dollars minus the fee